Table 1 |
||||||
|
Studies identified according to key features and predominant intervention strategy |
||||||
|
Educational |
Monitoring & Feedback |
Formulary* |
Collaborative Care Involving Pharmacists |
Disease Management† |
TOTAL |
|
|
|
||||||
|
All studies |
20 |
22 |
66 |
15 |
41 |
164 |
|
Methodologically acceptable studies |
7 |
16 |
15 |
5 |
8 |
51 |
|
RCT |
5 |
10 |
2 |
3 |
7 |
27 |
|
Interrupted time series |
0 |
5 |
5 |
0 |
0 |
10 |
|
Pre/post studies with comparison |
2 |
1 |
8 |
2 |
1 |
14 |
|
Interventions in methodologically acceptable studies‡ |
17 |
18 |
21 |
5 |
8 |
69 |
|
|
||||||
|
* published studies from 1966 through January 2007. † Only studies with pharmacotherapy as a primary focus. ‡ Studies may have examined more than one intervention and multiple studies may have examined the same intervention |
||||||
|
Lu et al. BMC Health Services Research 2008 8:75 doi:10.1186/1472-6963-8-75 |
||||||
